Does DEFLAZACORT Cause Product dose omission issue? 65 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Product dose omission issue have been filed in association with DEFLAZACORT (Deflazacort Oral Suspension). This represents 1.7% of all adverse event reports for DEFLAZACORT.
65
Reports of Product dose omission issue with DEFLAZACORT
1.7%
of all DEFLAZACORT reports
0
Deaths
11
Hospitalizations
How Dangerous Is Product dose omission issue From DEFLAZACORT?
Of the 65 reports, 11 (16.9%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEFLAZACORT. However, 65 reports have been filed with the FAERS database.
What Other Side Effects Does DEFLAZACORT Cause?
Weight increased (468)
Off label use (315)
Fall (206)
Vomiting (139)
Nasopharyngitis (134)
Abnormal behaviour (129)
Influenza (120)
Rash (114)
Headache (104)
Pyrexia (104)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which DEFLAZACORT Alternatives Have Lower Product dose omission issue Risk?
DEFLAZACORT vs DEGARELIX
DEFLAZACORT vs DELAFLOXACIN MEGLUMINE
DEFLAZACORT vs DELAMANID
DEFLAZACORT vs DELANDISTROGENE MOXEPARVOVEC-ROKL
DEFLAZACORT vs DELAVIRDINE